HS135

BIOLOGICAL2 trials

Sponsors

35Pharma Inc

Conditions

Heart Failure With Preserved Ejection FractionPulmonary Arterial Hypertension (PAH)Pulmonary Hypertension

Phase 1

A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

TerminatedNCT06493461

35Pharma IncPulmonary Arterial Hypertension (PAH)

Start: 2024-10-23End: 2025-03-31Updated: 2025-05-30

Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

TerminatedNCT06581159

35Pharma IncHeart Failure With Preserved Ejection Fraction, Pulmonary Hypertension

Start: 2025-01-23End: 2025-07-29Updated: 2025-09-04